C.RIVESIN — DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASES: TREATMENT OF INTERSTITAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. (Q2043648): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
(‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Property / financed by
 
Property / financed by: Directorate-General for Regional and Urban Policy / rank
Normal rank
 

Revision as of 09:39, 2 November 2020

Project Q2043648 in Italy
Language Label Description Also known as
English
C.RIVESIN — DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASES: TREATMENT OF INTERSTITAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION.
Project Q2043648 in Italy

    Statements

    0 references
    15,000.0 Euro
    0 references
    30,000.0 Euro
    0 references
    50.0 percent
    0 references
    18 July 2017
    0 references
    14 April 2018
    0 references
    23 October 2017
    0 references
    NEXTRARESEARCH SOCIETA' A RESPONSABILITA' LIMITATA
    0 references
    0 references

    45°28'0.48"N, 9°11'25.80"E
    0 references
    C.RIVESTIN - DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASE: TREATMENT OF INTERSTITIAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. (Italian)
    0 references
    C.RIVESIN — DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASES: TREATMENT OF INTERSTITAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. (English)
    0 references

    Identifiers

    E47F17001680002
    0 references